Next Article in Journal
Critical Role of Endoplasmic Reticulum Stress in Cognitive Impairment Induced by Microcystin-LR
Next Article in Special Issue
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism
Previous Article in Journal
Identification of Pathogenicity-Related Genes in Biofilm-Defective Acidovorax citrulli by Transposon Tn5 Mutagenesis
Previous Article in Special Issue
Benzene-Induced Aberrant miRNA Expression Profile in Hematopoietic Progenitor Cells in C57BL/6 Mice
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2015, 16(12), 28063-28076;

MicroRNAs: Clinical Relevance in Colorectal Cancer

Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA
Division of Oncology, Medical University of Graz, 8010 Graz, Austria
Author to whom correspondence should be addressed.
Academic Editor: Constantinos Stathopoulos
Received: 3 September 2015 / Revised: 27 October 2015 / Accepted: 13 November 2015 / Published: 25 November 2015
(This article belongs to the Collection Regulation by Non-Coding RNAs)
Full-Text   |   PDF [377 KB, uploaded 25 November 2015]   |  


Colorectal cancer is one of the most common cancer diagnoses and causes of mortality worldwide. MicroRNAs are a class of small, non-coding regulatory RNAs that have shown strong associations with colorectal cancer. Through the repression of target messenger RNAs, microRNAs modulate many cellular pathways, such as those involved in cell proliferation, apoptosis, and differentiation. The utilization of microRNAs has shown significant promise in the diagnosis and prognosis of colorectal cancer, owing to their unique expression profile associations with cancer types and malignancies. Moreover, microRNA therapeutics with mimics or antagonists show great promise in preclinical studies, which encourages further development of their clinical use for colorectal cancer patients. The unique ability of microRNAs to affect multiple downstream pathways represents a novel approach for cancer therapy. Although still early in its development, we believe that microRNAs can be used in the near future as biomarkers and therapeutic targets for colorectal cancer. View Full-Text
Keywords: colorectal cancer; miRNA; pathophysiology; diagnosis; prognosis; treatment colorectal cancer; miRNA; pathophysiology; diagnosis; prognosis; treatment

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Thomas, J.; Ohtsuka, M.; Pichler, M.; Ling, H. MicroRNAs: Clinical Relevance in Colorectal Cancer. Int. J. Mol. Sci. 2015, 16, 28063-28076.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top